What Is Hysterical Blindness? Symptoms and Causes

Hysterical blindness is an older term for a condition in which a person loses some or all of their vision without any detectable damage to the eyes or visual pathways in the brain. The eyes themselves work normally, and standard tests confirm that light reaches the retina and signals travel to the visual cortex, yet the person genuinely cannot see. Modern clinicians almost never use the phrase “hysterical blindness” anymore, preferring terms like functional visual loss or functional vision disorder, but the condition it describes is real, surprisingly common in certain clinical settings, and far more nuanced than its dramatic-sounding old name suggests.

Why the Name Changed

The word “hysterical” traces back to an era when unexplained symptoms in women were attributed to a wandering uterus. That baggage made the label both stigmatizing and misleading, since the condition affects men as well, and its roots lie in how the brain processes sensory information rather than in any gynecological phenomenon. Over the past few decades, the accepted terminology has cycled through several alternatives: non-organic vision loss, psychogenic vision loss, medically unexplained visual loss, and now functional vision disorder (FVD), which is aligned with how the DSM-5 classifies similar conditions across neurology under the umbrella of functional neurological disorder.¹ The shift to “functional” is deliberate: it signals that the nervous system is structurally intact but not functioning as expected, without implying that the patient is faking or that the problem is “all in their head.”

What the Symptoms Actually Look Like

If you imagine hysterical blindness as a sudden, total blackout affecting both eyes, the real picture is more varied and sometimes subtler. Vision loss can range from mild blurriness to severe impairment, and it usually affects both eyes at once. A large systematic review pulling together data from multiple studies found that bilateral visual acuity loss was the most common presentation, appearing in roughly 70 to 85 percent of patients depending on the cohort studied.² Some people lose only part of their visual field rather than overall sharpness. The most frequently reported field abnormality is concentric narrowing, sometimes called “tunnel vision,” where the periphery disappears and the person can see only a shrinking central spot. Spiral visual fields, where the visible area contracts further with each pass of testing, also show up in about a quarter of cases in some studies.

Other visual complaints that ride alongside the main vision loss include blurred or distorted vision, difficulty seeing in dim lighting, double vision, and occasionally flashes of light. In one study of 133 patients, convergence spasm, where the eyes inappropriately turn inward, appeared in about a fifth of cases, while drooping eyelids and involuntary eye closure were much rarer, each occurring in only a few percent.² One hallmark that clinicians look for is inconsistency: the degree of vision loss can change between tests done minutes apart, or the person may navigate a room more easily than their measured acuity would predict. That inconsistency is not evidence of dishonesty. It reflects the fluctuating, involuntary nature of the condition.

What Causes It

There is no single cause. Functional visual loss sits at the intersection of psychological stress, how the brain filters sensory input, and individual vulnerability. The condition belongs to the broader family of functional neurological disorders, where the brain’s normal processing of sensation or movement goes awry without structural damage. What separates this from, say, a stroke affecting the visual cortex is that the hardware is fine; the software is misfiring.

Psychological stress is the factor most consistently linked to onset. In adults, accidents or physical trauma were the most commonly reported precipitating events in one comparative analysis, cited by roughly a third of adult patients.³ In children, family or home stress topped the list. That same review found that a history of psychiatric disorders was present in about 42 percent of adults and 23 percent of children with functional visual loss. Research on the broader relationship between prolonged mental stress and the visual system suggests that sustained stress and elevated cortisol can disrupt the autonomic nervous system and vascular regulation in ways that affect the eye and brain, though the precise pathway leading to functional blindness as opposed to other stress-related vision problems remains poorly understood.⁴

Not every patient has an obvious psychological trigger, however. About one in five patients in one large study had migraine, facial pain, or coexisting organic eye disease alongside their functional symptoms.⁵ That overlap complicates the picture: the brain may be more likely to develop functional visual loss when it is already dealing with pain signals or a pre-existing visual problem, even a mild one like amblyopia (lazy eye).

Who Gets It

Functional visual loss is not vanishingly rare. It shows up in ophthalmology and neuro-ophthalmology clinics regularly enough that large case series exist. A meta-analysis pooling over 2,200 patients across 41 studies found that roughly two-thirds of those affected were female, with a pooled proportion of about 67 percent.⁶ The female predominance was a bit more pronounced in children (around 70 percent) than in adult-only cohorts (around 62 percent), though the difference was not statistically significant.

Age at presentation tends to cluster in two groups. In pediatric studies, the typical age is between 8 and 14. In adult studies, it clusters around 35 to 45. The youngest reported patient was 3.5 years old, and the oldest was 89.⁶ The condition can appear at virtually any age, but these two clusters suggest that developmental stressors in adolescence and cumulative life stressors in mid-adulthood are particularly potent windows.

How Children Differ from Adults

The broad strokes of the condition look similar in kids and adults, but the triggers and the long-term outlook diverge in meaningful ways. Children’s precipitating factors lean heavily toward stressors in the home and at school. In a study of 71 children with non-organic visual loss, significant home and school stress was uncovered in about 31 percent, previously diagnosed psychiatric issues like anxiety, depression, or ADHD were present in about 27 percent, and roughly 23 percent simply wanted to wear glasses, with no deeper psychological distress identified.⁷ That last group is worth noting: some children’s visual complaints appear to be a form of attention-seeking or peer imitation rather than a response to trauma. Among the children who wanted glasses, girls outnumbered boys by three to one.

A separate prospective study found that the most common presenting symptom in children was binocular reduced visual acuity, and that pattern-reversal visual evoked potentials, an objective measure of whether signals from the eye reach the brain normally, came back normal in every patient tested.⁸ That finding underscores the core paradox of functional visual loss: the visual system is demonstrably working, yet the child genuinely reports not being able to see well.

Visual field defects appear to be less common in children than in adults. One comparative analysis found that visual field defects occurred in about half of children compared with 86 percent of adults, even though rates of visual acuity loss were similar between the two groups.³ The reason for this difference is not entirely clear, though it may partly reflect the difficulty of performing reliable visual field testing in younger children.

How It Is Diagnosed

Diagnosing functional visual loss is often a process of exclusion combined with positive confirmation, and it tends to take a while. A study of 110 patients found that, on average, each person had seen nearly four different medical specialists before finally landing in a neuro-ophthalmology clinic, with an average of about five healthcare visits and more than two neuroimaging studies per patient.⁹ Fifteen percent had undergone unnecessary treatments along the way, including steroids, visual therapy, and prisms. That diagnostic odyssey is both expensive and stressful, and it sometimes reinforces the patient’s belief that something dire is wrong with their eyes.

The clinical examination uses a series of bedside techniques and maneuvers designed to show that the visual system is functioning better than the patient reports. These are not “gotcha” tests meant to catch someone lying. They are tools for demonstrating to both the clinician and the patient that the capacity for vision is still intact.¹⁰ For example, a person who claims total blindness in one eye but whose pupils react normally to light in that eye is showing objective evidence of a working pathway. Tests like the optokinetic drum, which triggers involuntary eye-tracking movements, can reveal that the visual cortex is processing images even when the person says they see nothing.

When bedside tests are ambiguous, electrophysiology can help. Visual evoked potentials and electroretinography provide objective, quantifiable assessments of whether the retina is detecting light and whether signals are arriving in the brain’s visual cortex. A normal result on these tests in someone reporting significant vision loss strongly supports a functional diagnosis.¹¹ The emphasis in modern clinical practice is on making a “positive diagnosis,” meaning one based on demonstrations that vision is present, rather than simply declaring the diagnosis because nothing structural was found on an MRI.

Functional Visual Loss Versus Faking

This is the question that follows the condition like a shadow, and it deserves a direct answer: the overwhelming majority of people with functional visual loss are not faking. The distinction between a functional disorder and malingering is that malingering is deliberate deception for a tangible gain, like an insurance payout or avoiding military service. Functional visual loss, by contrast, is an involuntary condition. The person is not choosing to not see. Their brain is failing to process visual information in a way they cannot consciously override.

Clinicians who specialize in the area are generally practiced at distinguishing the two, though it is not always straightforward. Certain patterns raise red flags for malingering: inconsistencies that only appear when the patient knows they are being observed, a clear external incentive, and a lack of distress about the vision loss. Patients with genuine functional visual loss, on the other hand, are usually distressed, cooperative with testing, and may even be relieved when a clinician tells them their eyes are structurally healthy. The clinical literature is quite clear that the default assumption should be that the patient is not faking, and that the diagnosis should focus on demonstrating preserved visual function rather than on trying to “catch” the patient.

Treatment and How to Deliver the Diagnosis

How the diagnosis is communicated matters enormously. Telling a patient “there’s nothing wrong with your eyes” is both technically true and practically harmful, because it dismisses a real experience. The current recommended approach emphasizes explanation and reassurance: the clinician walks the patient through the test results, showing them the objective evidence that their visual system can work, and then explains the concept of a functional disorder in plain terms. The goal is to reframe the problem from “mystery illness” to “brain software glitch that can improve.”

The first-line treatment for functional visual loss is this combination of education and reassurance. Beyond that, the evidence base thins out considerably. Case reports describe benefit from psychotherapy, hypnosis, and transcranial magnetic stimulation, but no large randomized trials have compared these approaches head to head.¹² A practical management framework published in 2024 recommends several steps beyond the initial explanation: looking for comorbid conditions like migraine or idiopathic intracranial hypertension that may be amplifying symptoms, working with an orthoptist who can use diagnostic tests in a positive way to highlight the patient’s capacity for better vision, developing strategies for common accompanying symptoms like photophobia, and considering psychological assessment as one part of a broader evaluation rather than the sole focus.¹³

Promising future directions mentioned in the literature include hypnotherapy, transcranial magnetic stimulation, and more advanced forms of visual feedback, but these remain early-stage and are not yet standard care.

Prognosis

Recovery rates vary widely and depend a lot on age. Children do remarkably well. In pediatric studies that tracked complete remission, recovery rates ranged from 92 to 96 percent.² For adults, the picture is less rosy. Studies that tracked symptom improvement in mixed or adult populations reported recovery rates as low as 14 percent and as high as 86 percent, a range so broad it reflects just how much variation exists in how the condition is defined, treated, and followed up. Estimates suggest that up to 60 percent of adults continue to have symptoms that affect their daily life at long-term follow-up.¹³

Why children recover more readily is not entirely settled. One likely factor is that the underlying stressors in children, such as school difficulties or family disruption, may be more amenable to change or resolution than the accumulated trauma or chronic stress often seen in adults. Children’s brains may also be more neuroplastic and quicker to “reset” the aberrant processing patterns. Whatever the mechanism, the clinical consensus is that early, clear diagnosis and age-appropriate reassurance are the strongest predictors of a good outcome.

The Healthcare Burden of Delayed Diagnosis

The winding road to diagnosis is one of the most frustrating aspects of functional visual loss, for patients and for the healthcare system alike. As noted in the study of 110 patients, the average person bounced between nearly four specialists and accumulated more than two brain or orbital imaging studies before a neuro-ophthalmologist made the call.⁹ Each of those visits and imaging sessions carries costs, and more importantly, each one that fails to provide an answer deepens the patient’s anxiety and may reinforce illness behavior. The 15 percent who received unnecessary treatments, including systemic steroids with their own side-effect profiles, illustrate how a missed or delayed functional diagnosis can lead to real medical harm.

Greater awareness among general ophthalmologists and optometrists could shorten this journey. The condition is well described in the neuro-ophthalmology literature, but clinicians in frontline eye care may not encounter it often enough to feel confident making the diagnosis. When they do suspect it, referring promptly rather than ordering yet another round of imaging benefits everyone involved.

Cultural and Historical Context

Functional visual loss does not occur in a cultural vacuum. A striking example comes from a study of Southeast Asian refugees in California during the 1980s. Cambodian refugees accounted for a vastly disproportionate share of functional visual loss cases despite making up only 20 to 30 percent of the local Southeast Asian patient population. Many had histories of camp incarceration and severe wartime trauma.¹⁴ The authors interpreted the findings as conversion reactions influenced by the extreme stress of the Khmer Rouge period and its aftermath. In some Cambodian cultural frameworks, having “seen too much” violence could translate into a literal inability to see, a metaphor made physical by the brain’s stress response.

This study also highlights something broader: that the form a functional neurological symptom takes is shaped by cultural expectations and personal history. In settings where vision carries strong symbolic weight, or where psychological distress lacks an acceptable outlet, visual loss may become the body’s language for communicating suffering. Understanding that context does not make the vision loss less real. It does, however, change how a clinician might approach the conversation about diagnosis and recovery, particularly in multicultural healthcare settings where patients and doctors may bring different models of illness to the encounter.

The Relationship Between Vision Loss and Mental Health

Functional visual loss exists against a backdrop of well-documented links between visual impairment and psychiatric health. Rates of depression and anxiety are elevated among people with visual impairments of all kinds, and individuals from lower socioeconomic backgrounds face a compounded risk of both vision problems and subsequent mental health difficulties.¹⁵ For someone with functional visual loss, this creates a feedback loop: the vision loss generates anxiety and depression, and that worsening mental health may in turn perpetuate the functional symptoms. Breaking that cycle is one reason the current management approach emphasizes psychological support alongside visual rehabilitation rather than treating either in isolation.

Complicating matters further, some patients develop functional visual loss on top of a real, organic eye condition. Having an actual visual impairment does not immunize someone against also developing a functional overlay. When the two coexist, teasing apart what portion of vision loss is structural and what is functional demands careful testing and clinical judgment. Patients in this gray zone are among the most challenging to diagnose and the most vulnerable to being told either that they are exaggerating or that their problem is entirely physical.